News from foamix pharmaceuticals ltd A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jun 29, 2017, 08:00 ET Foamix Pharmaceuticals Appoints David Domzalski as Chief Executive Officer

Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), ("Foamix"), a clinical stage specialty pharmaceutical company focused on developing and commercializing...


May 09, 2017, 16:05 ET Foamix Reports First Quarter 2017 Financial Results and Provides Business Update

Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) ("Foamix Pharmaceuticals" or the "Company"), a clinical stage specialty pharmaceutical company focused on...


May 01, 2017, 16:05 ET Foamix Pharmaceuticals Announces Plans for Additional Phase 3 Trial for FMX101 in Moderate to Severe Acne

Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), ("Foamix"), a clinical stage specialty pharmaceutical company focused on developing and commercializing...


Apr 27, 2017, 08:00 ET Foamix Pharmaceuticals to Present at the 42nd Annual Deutsche Bank Health Care Conference

Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), ("Foamix"), a clinical stage specialty pharmaceutical company focused on developing and commercializing...


Apr 26, 2017, 08:30 ET Foamix Pharmaceuticals First Quarter Financial Results Conference Call & Webcast Scheduled for Wednesday, May 10

Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), ("Foamix Pharmaceuticals"), a clinical stage specialty pharmaceutical company focused on developing and...


Mar 27, 2017, 07:30 ET Foamix Reports Topline Results from Phase 3 Trials for FMX101 in Patients with Acne

Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), today announced the topline results of its two Phase 3 clinical trials investigating FMX101, Trial 04 and ...


Mar 08, 2017, 07:00 ET Foamix Pharmaceuticals to Present at the Barclays Capital Global Healthcare Conference

Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), ("Foamix"), a clinical stage specialty pharmaceutical company focused on developing and commercializing...


Feb 22, 2017, 07:00 ET Foamix Reports Year End 2016 Financial Results and Provides Business Update

Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) ("Foamix" or the "Company"), a clinical stage specialty pharmaceutical company focused on developing and...


Nov 28, 2016, 08:30 ET Foamix Announces Completion of Patient Enrollment in Phase 3 Acne Trials for Minocycline Foam FMX101

Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) ("Foamix" or the "Company"), a clinical stage specialty pharmaceutical company focused on developing and...


Nov 15, 2016, 04:15 ET Foamix Reports Third Quarter 2016 Financial Results and Provides Business Update

Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) ("Foamix Pharmaceuticals" or the "Company"), a clinical stage specialty pharmaceutical company focused on...


Nov 10, 2016, 08:00 ET Foamix Pharmaceuticals to Present at Jefferies London Healthcare Conference on November 17

Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), ("Foamix"), a clinical stage specialty pharmaceutical company focused on developing and commercializing...


Nov 07, 2016, 08:00 ET Foamix Pharmaceuticals to Release Third Quarter 2016 Financial Results and Host Conference Call & Webcast on Wednesday, November 16

Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), ("Foamix"), a clinical stage specialty pharmaceutical company focused on developing and commercializing...


Nov 03, 2016, 08:00 ET Foamix Pharmaceuticals to Present at the 25th Annual Credit Suisse Healthcare Conference on November 7

Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), ("Foamix"), a clinical stage specialty pharmaceutical company focused on developing and commercializing...


Sep 09, 2016, 08:00 ET Foamix to Announce Topline Results in Phase 2 Clinical Trial of FMX-103 Minocycline Topical Foam for Moderate-to-Severe Papulopustular Rosacea

Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), ("Foamix"), a clinical stage specialty pharmaceutical company focused on developing and commercializing...